1) Evaluation of outcome measures for neurogenic claudication and 2) Topic of the month: Neurology Today: Recent Publications. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. John Markman about his paper on a patient-centered approach for evaluation of outcome measures for neurogenic claudication. Dr. Ted Burns is interviewing Dr. Robert Gross for our “What's Trending” feature of the week about Neurology's spoke journals. In the next part of the podcast Dr. Ted Burns interviews Dr. Steve Ringel about a Neurology Today story on the topic of acute flaccid myelitis. The participants had nothing to disclose except Drs. Burns, Markman and Ringel.Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Dr. Markman serves on the scientific advisory board for Allergan, Inc., Pfizer Inc, Purdue Pharma L. P., Chromocell Corporation, Plasma Surgical, Nektar, Depomed, Inc., Regeneron Pharmaceuticals; serves as an editorial board member of Merck Serono; is a consultant for Xian Janssen Pharmaceutical Ltd. and Nektar; receives research support from Depomed, Inc., Pfizer Inc and as a special government employee of the Food and Drug Administration.Dr. Gross is supported for educational endeavors from the University of Rochester Medical Center's Clinical and Translational Science Award from the NIH, since his appointment as Editor-in-Chief in 2009, he has ceased participation in industry-sponsored clinical trials and speakers' bureaus, receives an honorarium from AAN as Editor-in-Chief of Neurology.Dr. Ringel serves as editor of Neurology Today.